Active agent for regeneration of the lung

Medicamentous regeneration of forms of lung damage as a result of chronic lung diseases such as COPD, pulmonary fibrosis, asthma etc. is possible for the first time thanks to the new active agent.
The novel active agent may remove the necessity of having to undergo a risky lung transplantation and could cure the disease, making it of interest to a broad patient population.


TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0